Literature DB >> 30948784

Regioselective single pot C3-glycosylation of strophanthidol using methylboronic acid as a transient protecting group.

Jia-Hui Tay1, Valentin Dorokhov2, Sibin Wang1, Pavel Nagorny3.   

Abstract

This manuscript describes a single pot protocol for the selective introduction of unprotected sugars to the C3 position of the cardiotonic steroid strophanthidol. These reactions proceed with high levels of regiocontrol (>20:1 rr) in the presence of three other hydroxyl functionalities including the C19 primary hydroxyl group and could be applied to different sugars to provide the deprotected cardiac glycosides upon work up (5 examples, 77-69% yield per single operation). The selective glycosylation of the less reactive C3 position is accomplished by the use of traceless protection with methylboronic acid that blocks the C5 and C19 hydroxyls by forming a cyclic boronic ester, followed by in situ glycosylation and a work up with ammonia in methanol to remove the boronic ester and the carbohydrate ester protecting groups.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30948784      PMCID: PMC6486442          DOI: 10.1038/s41429-019-0172-1

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  35 in total

Review 1.  The digitalis-like steroid hormones: new mechanisms of action and biological significance.

Authors:  Maoz Nesher; Uri Shpolansky; Haim Rosen; David Lichtstein
Journal:  Life Sci       Date:  2007-04-01       Impact factor: 5.037

Review 2.  Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth.

Authors:  Wilhelm Schoner; Georgios Scheiner-Bobis
Journal:  Am J Physiol Cell Physiol       Date:  2007-05-09       Impact factor: 4.249

Review 3.  Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets.

Authors:  Alexei Y Bagrov; Joseph I Shapiro; Olga V Fedorova
Journal:  Pharmacol Rev       Date:  2009-03       Impact factor: 25.468

4.  Total synthesis of ouabagenin and ouabain.

Authors:  Maddi Sridhar Reddy; Hongxing Zhang; Serge Phoenix; Pierre Deslongchamps
Journal:  Chem Asian J       Date:  2009-05-04

5.  Copper(II)-Catalyzed Tandem Decarboxylative Michael/Aldol Reactions Leading to the Formation of Functionalized Cyclohexenones.

Authors:  Jeonghyo Lee; Sibin Wang; Miranda Callahan; Pavel Nagorny
Journal:  Org Lett       Date:  2018-03-21       Impact factor: 6.005

6.  Cytotoxic cardiac glycosides and coumarins from Antiaris toxicaria.

Authors:  Li-Shian Shi; Sheng-Chu Kuo; Han-Dong Sun; Susan L Morris-Natschke; Kuo-Hsiung Lee; Tian-Shung Wu
Journal:  Bioorg Med Chem       Date:  2014-02-06       Impact factor: 3.641

7.  Enhancing the anticancer properties of cardiac glycosides by neoglycorandomization.

Authors:  Joseph M Langenhan; Noël R Peters; Ilia A Guzei; F Michael Hoffmann; Jon S Thorson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-16       Impact factor: 11.205

Review 8.  Novel therapeutic applications of cardiac glycosides.

Authors:  Ioannis Prassas; Eleftherios P Diamandis
Journal:  Nat Rev Drug Discov       Date:  2008-10-24       Impact factor: 84.694

Review 9.  Rostafuroxin: an ouabain antagonist that corrects renal and vascular Na+-K+- ATPase alterations in ouabain and adducin-dependent hypertension.

Authors:  Patrizia Ferrari; Mara Ferrandi; Giovanni Valentini; Giuseppe Bianchi
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-03       Impact factor: 3.619

Review 10.  Anticancer and Immunogenic Properties of Cardiac Glycosides.

Authors:  Naira Fernanda Zanchett Schneider; Claudia Cerella; Cláudia Maria Oliveira Simões; Marc Diederich
Journal:  Molecules       Date:  2017-11-08       Impact factor: 4.411

View more
  1 in total

1.  Recent Progress in Steroid Synthesis Triggered by the Emergence of New Catalytic Methods.

Authors:  Hem Raj Khatri; Nolan Carney; Ryan Rutkoski; Bijay Bhattarai; Pavel Nagorny
Journal:  European J Org Chem       Date:  2020-01-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.